Document:

exv10w1

Exhibit 10.1

EMPLOYMENT AGREEMENT

     This Employment Agreement (“Agreement”), is made and entered into this 4th day of April, 2011,
(the “Effective Date”) by and between Wright Medical Technology, Inc. (“Company”), a corporation
organized and existing under the laws of the State of Delaware with its principal place of business
at 5677 Airline Road, Arlington, Tennessee 38002, and David D. Stevens (“Executive”).

     WHEREAS, the Company desires to employee Executive as its interim President and Chief
Executive Officer to report to the Executive Committee of the Company’s Board of Directors; and

     WHEREAS, the Company and the Executive desire to set forth the terms and conditions of
Executive’s employment with Company as the interim President and Chief Executive Officer;

     NOW, THEREFORE, for and in consideration of the mutual covenants contained in this Agreement,
Company and Executive agree as follows:

     1. Definitions. For the purposes of this Agreement, the following capitalized terms
have the meanings set forth below:

          1.1. “Accrued Obligations” means a lump sum amount in cash equal to the sum of (i) the
Executive’s annual base salary through the Date of Termination to the extent not theretofore paid,
(ii) an amount equal to the value of any accrued and/or untaken vacation, if any, and (iii)
reimbursement for unreimbursed business expenses, if any, properly incurred by the Executive in the
performance of the Executive’s duties in accordance with the policies established from time to time
by the Board.

          1.2. “Affiliate” has the meaning set forth in Rule 12b-2 promulgated under the Exchange Act.

          1.3. “Compensation Committee” means the compensation committee of the Board.

          1.4. “Competitive Business” means the manufacturing, supplying, producing, selling,
distributing, marketing or providing for sale of any product, device or instrument manufactured or
sold by the Company or any of its Affiliates or subsidiaries, in each case as of the Executive’s
Date of Termination or the Expiration Date.

          1.5. “Exchange Act” means the Securities Exchange Act of 1934, as amended, and the applicable
rulings and regulations thereunder.

 

 

			
	Wright Medical Technology, Inc.	 	
	Employment Agreement — David Stevens
	 	CONFIDENTIAL
	Page 2
	 	DO NOT COPY

          1.6. “Incentive Compensation Awards” means awards granted under Incentive Compensation Plans
providing the Executive with the opportunity to earn, on a year-by-year or a multi-year basis,
annual and long-term incentive compensation.

          1.7. “Incentive Compensation Plans” means annual incentive compensation plans and long-term
incentive compensation plans of the Company, which long-term incentive compensation plans may
include plans offering stock options, restricted stock and other forms of long-term incentive
compensation.

          1.8. “Person” has the meaning set forth in Section 3(a)(9) of the Exchange Act, as modified
and used in sections 13 and 14 thereof, except that the term shall not include (i) the Company or
any of its Affiliates, (ii) a trustee or other fiduciary holding securities under an employee
benefit plan of the Company or any of its Affiliates, (iii) an underwriter temporarily holding
securities pursuant to an offering of such securities, (iv) a corporation owned, directly or
indirectly, by the shareholders of the Company in substantially the same proportions as their
ownership of the stock in the Company, or (v) a person or group as used in Rule 13d-1(b)
promulgated under the Exchange Act.

     2. Employment. The Company hereby employs the Executive, and the Executive hereby
accepts employment, upon the terms and conditions herein set forth.

     3. Duties. The Executive is engaged as the interim President and Chief Executive
Officer of the Company and shall report to the Executive Committee of the Board of Directors of the
Company (“Board”) and hereby promises to perform and discharge well and faithfully the duties which
may be assigned to him from time to time by the Board in connection with the conduct of the
Company’s business.

     4. Extent of Services. The Executive shall devote his time, attention, and energies
to the business of the Company and shall not, without the approval of the Company, during the term
of this Agreement be engaged in any other business activity, regardless of whether such activity is
pursued for gain, profit or other pecuniary advantage; provided, however, that this requirement
shall not be construed as preventing the Executive from (a) investing his personal assets in
businesses which do not compete with the Company in such form or manner as will not require any
services on the part of the Executive in the operation of the affairs of the companies in which
such investments are made and in which his participation is solely that of an investor, or (b)
purchasing securities in any corporation engaged in a business competitive to that of the Company
whose securities are regularly traded on the Nasdaq Stock Market, a national or regional stock
exchange, or the over-the-counter market, provided that such purchase shall not result in his
collectively owning beneficially at any one time one percent (1%) or more of the equity securities
of such corporation. Nothing in this Section 4 shall prevent the Executive from continuing to
service on the Board or the board of directors of any other company or from continuing his prior
business activities for any other company.

     5. Compensation Matters.

 

 

			
	Wright Medical Technology, Inc.	 	
	Employment Agreement — David Stevens
	 	CONFIDENTIAL
	Page 3
	 	DO NOT COPY

          5.1. Base Salary. For services rendered under this Agreement, the Company shall pay
the Executive a base annualized salary of $610,000 ( “Base Salary”), which shall be payable (after
deduction of applicable payroll taxes) in accordance with the Company’s customary payroll practices
in effect from time to time.

          5.2. Equity Incentive Plan Awards. The Executive shall receive an award of 39,400
restricted shares pursuant to the terms of the Company’s 2009 Equity Incentive Plan, as the same
may be amended from time to time (“Equity Plan”), effective as of May 3, 2011. Any such grant of
stock options or other awards under the Equity Plan shall be made in accordance with and subject to
the terms of the Equity Plan and any agreement pursuant to which such stock options or other awards
are granted. The restricted shares will vest 12 months from the Effective Date.

          5.3. Fringe Benefits. The Executive shall be eligible to receive and to participate
in programs for, such fringe benefits (including, without limitation, medical insurance and
retirement benefits) as the Company may make available generally to its executive officers from
time to time during the term of this Agreement. The Executive shall be responsible for making any
generally applicable employee contributions required under such fringe benefit programs.

     6. Sick Leave and Vacation. During the term of this Agreement, the Executive shall be
entitled to annual vacation of at least four (4) weeks, or such greater time period if permitted by
Company policy, to be taken at his discretion in a manner consistent with his obligations to the
Company under this Agreement. The actual dates of such vacation periods shall be agreed upon
through mutual discussions between the Company and the Executive; provided, however, that the
Company shall have the ultimate decision with respect to the actual vacation dates to be taken by
the Executive, which decision shall not be unreasonable. The purpose of such vacation is to permit
personal rest and relaxation for the Executive and it not intended to be used for Executive’s
ancillary business and public activities such as attendance at conferences, board meetings or
public or charitable event. The Executive also shall be entitled to sick leave consistent with
Company policy.

     7. Expenses. During the term of this Agreement, the Company shall reimburse the
Executive for all reasonable out-of-pocket expenses incurred by the Executive in connection with
the business of the Company and in performance of his duties under this Agreement and in connection
with reasonable travel between Memphis and Executive’s primary residence in Florida. Expenses
shall be reimbursed upon the Executive’s presentation to the Company of an itemized accounting of
such expenses with reasonable supporting data.

     8. Term. Executive’s employment by the Company under this Agreement shall commence on
the Effective Date and shall expire on the first anniversary of the Effective Date unless
otherwise extended by written agreement or upon the Company’s employment of a President and Chief
Executive Officer, whichever shall come first in time (the “Expiration Date”). Notwithstanding the
foregoing but subject to Section 10, Company, in its sole and

 

 

			
	Wright Medical Technology, Inc.	 	
	Employment Agreement — David Stevens
	 	CONFIDENTIAL
	Page 4
	 	DO NOT COPY

absolute discretion, or the Executive may terminate the Executive’s employment and the
Company’s obligations hereunder.

     9. Termination and Effects of Termination.

          9.1. Notice and Date of Termination.

               9.1.1. Notice. Any termination of the Executive’s employment by the Company or by the
Executive prior to the Expiration Date shall be communicated by a written notice of termination to
the other party (the “Notice of Termination”). Where applicable, the Notice of Termination shall
indicate the specific termination provision in this Agreement relied upon and shall set forth in
general terms the facts and circumstances claimed to provide a basis for termination of the
Executive’s employment under the provision so indicated. Any termination by resignation by
Executive shall provide the Company with not less than four (4) weeks notice.

               9.1.2. Date. The date of the Executive’s termination of employment with the Company (
“Date of Termination”) shall be determined as follows:

                    9.1.2.1. If due to Company terminating the Executive’s employment, either with or without
Cause, the Date of Termination shall be the date specified in the Notice of Termination; if for
other than Cause, the Date of Termination shall not be less than two (2) weeks from the date such
Notice of Termination is given, unless the Company elects to pay the Executive for that period in
lieu of notice. Any such payment in lieu of notice would be in addition to any payments provided
pursuant to Section 9.3

                    9.1.2.2. If due to death, the Date of Termination is the date of death.

                    9.1.2.3. If due to resignation by the Executive, the Date of Termination shall be determined
by the Company, but shall not be less than four (4) weeks from the date such Notice of Termination
is given.

          9.2. Termination for Cause or Resignation by Executive and Effects Thereof.

               9.2.1. Termination for Cause. The Company may terminate Executive for the
following reasons: (i) the willful failure by the Executive to substantially perform the
Executive’s duties with the Company (other than any such failure resulting from the Executive’s
incapacity due to physical or mental illness) as determined by the Board, which failure amounts to
an intentional and extended neglect of the Executive’s duties, (ii) continued, documented poor
performance on the part of the Executive following a reasonably sufficient time for the Executive
to improve, (iii) the determination by the Board, in its sole discretion, that the Executive has
engaged or is about to engage in conduct materially injurious to the Company, (iv) the
determination by the Board, in its sole discretion, that the Executive has engaged in or is about
to engage in conduct that is materially inconsistent with the Company’s legal and health

 

 

			
	Wright Medical Technology, Inc.	 	
	Employment Agreement — David Stevens
	 	CONFIDENTIAL
	Page 5
	 	DO NOT COPY

care compliance policies, programs or obligations; (v) the Executive’s conviction of or
entering of a guilty or no contest plea to a felony charge (or equivalent thereof) in any
jurisdiction; and/or (iv) the Executive’s participation in activities proscribed in Sections 12.1,
12.3, and 12.4 or the material breach of any other covenants contained herein. (“Cause”). For the
purposes of clause (i) of this definition, no act, or failure to act, on the Executive’s part shall
be deemed to be “willful” unless done, or omitted to be done, by the Executive not in good faith
and without reasonable belief that the Executive’s act, or failure to act, was in the best
interests of the Company.

               9.2.2. Effects of Termination for Cause or Resignation by Executive. If the
Executive’s employment shall be terminated for Cause, or if the Executive resigns employment, the
Company will have no further obligations to the Executive under this Agreement other than the
Accrued Obligations. The Executive shall also be eligible for health and dental coverage as
provided for under COBRA, using the normal COBRA administration process of the Company.

          9.3. Involuntary Termination Other Than for Cause and Effects Thereof. :

                    9.3.1. Involuntary Termination Other Than for Cause. The Company can terminate the employment
of Executive for any reason other than Cause subject to the terms of this Agreement.

                    9.3.2. Effects of Involuntary Termination Other Than for Cause. If the Executive’s employment
is terminated for any reason other than for Cause, the Company will be obligated to continue the
Base Salary of Executive for a period of 8 weeks in addition to the payment of the Accrued
Obligations. The Executive shall also be eligible for health and dental coverage as provided for
under COBRA, using the normal COBRA administration process of the Company. Payments of Base Salary
continuation pursuant to Section 9.3.2 shall be subject to the Company’s prior receipt of an
executed and effective Release that has not been revoked prior to any payment.

          9.4. Termination due to Death. If the Executive’s employment shall terminate by
reason of death, the Company shall pay the Executive’s estate the Accrued Obligations. Such
payments shall be in addition to those rights and benefits to which the Executive’s estate may be
entitled under the relevant Company plans or programs.

          9.5. Equity Based Compensation. Notwithstanding any other provision herein, all
equity based Incentive Compensation Awards held by Executive shall be governed by the terms of the
applicable Incentive Compensation Plan and Incentive Compensation Award agreement and this
Agreement shall have no effect on them.

          9.6. Nonexclusivity of Rights. Nothing in this Agreement shall prevent or limit the
Executive’s continuing or future participation in any benefit plan, program, policy or practice
provided by the Company and for which the Executive may qualify (except with respect to any
benefit to which the Executive has waived the Executive’s rights in writing), including,
without

 

 

			
	Wright Medical Technology, Inc.	 	
	Employment Agreement — David Stevens
	 	CONFIDENTIAL
	Page 6
	 	DO NOT COPY

limitation, any and all indemnification arrangements in favor of the Executive (whether
under agreements or under the Company’s charter documents or otherwise), and insurance policies
covering the Executive, nor shall anything herein limit or otherwise affect such rights as the
Executive may have under any other contract or agreement entered into after the Effective Date with
the Company. Amounts which are vested benefits or which the Executive is otherwise entitled to
receive under any benefit, plan, policy, practice or program of, or any contract or agreement
entered into with, the Company shall be payable in accordance with such benefit, plan, policy,
practice or program or contract or agreement except as explicitly modified by this Agreement.

          9.7. Indemnification. At all times during the Executive’s employment with the
Company and thereafter, the Company shall provide the Executive with indemnification and director
and officer insurance insuring the Executive against insurable events which occur or have occurred
while the Executive was a director or executive officer of the Company, on terms and conditions
that are at least as generous as that then provided to any other current or former director or
executive officer of the Company or any Affiliate.

     10. Mitigation. In no event shall the Executive be obligated to seek other employment
or take any other action by way of mitigation of the amounts (including amounts for damages for
breach) payable to the Executive under any of the provisions of this Agreement, and such amounts
shall not be reduced whether or not the Executive obtains other employment.

     11. Representations. The Executive hereby represents to the Company that the
Executive is legally entitled to enter into this Agreement and to perform the Executive’s
obligations hereunder, and that the Executive has the full right, power and authority to grant to
the Company the rights contemplated in Section 12.2.

     12. Executive’s Covenants. The Executive hereby agrees to the following:

          12.1. Confidentiality. The Executive recognizes and acknowledges that the Company’s
and its predecessor’s Confidential Information is a valuable, special and unique asset of the
Company’s businesses, access to and knowledge of which are essential to the performance of the
Executive’s duties. Confidential Information shall include trade secrets and includes information
acquired by the Executive in the course and scope of the Executive’s job with the Company,
including information acquired from third parties, that is (i) not generally known or disseminated
outside the Company (such as nonpublic information), (ii) is designated or marked by the Company as
“confidential” or reasonably should be considered confidential or proprietary, or (iii) the Company
indicates through its policies, procedures or other instructions should not be disclosed to anyone
outside the Company. Without limiting the foregoing definitions, some examples of Confidential
Information under this Agreement include (a) matters of a technical nature, such as scientific,
trade or engineering secrets, “know-how”, formulae, secret processes, inventions, and research and
development plans or projects regarding existing and prospective customers, and products and
services, (b) information about costs, profits,
markets, sales, customer lists, customer needs, customer preferences and customer purchasing
histories, supplier lists, internal financial data, personnel evaluations, nonpublic information

 

 

			
	Wright Medical Technology, Inc.	 	
	Employment Agreement — David Stevens
	 	CONFIDENTIAL
	Page 7
	 	DO NOT COPY

about
medical devices or products of the Company (including future plans about them), information
and material provided by third parties in confidence and/or with nondisclosure restrictions,
computer access passwords, and internal market studies or surveys and (c) any other information or
matters of a similar nature. The Executive shall not, during or after the Executive’s employment
by the Company, in whole or in part, disclose such Confidential Information to any person, firm,
corporation, association or other entity for any reason or purpose whatsoever, nor shall the
Executive make use of any such property for the Executive’s own purposes or for the benefit of any
person firm, corporation, association or other entity (except the Company) under any circumstances
during or after the Executive’s employment by the Company; provided, however, that after the
Executive’s employment by the Company ceases these restrictions shall not apply to such
Confidential Information, if any, which are then in the public domain, and provided further that
the Executive was not responsible, directly or indirectly, for such Confidential Information
entering the public domain without the Company’s consent.

          12.2. Inventions. The Executive hereby sells, transfers and assigns to the Company
or to any person or entity designated by the Company all of the right, title and interest of the
Executive in and to all inventions, ideas, disclosures and improvements, whether patented or
unpatented, and copyrightable material, made or conceived by the Executive, solely or jointly,
during the Executive’s employment by the Company or any of its predecessors which relate to
methods, apparatus, designs, products, processes or devices sold, leased, used or under
consideration or development by the Company or any of its predecessors, or which otherwise relate
to or pertain to the business, functions or operations of the Company or any of its predecessors,
or which arise from the efforts of the Executive during the Executive’s employment with the Company
or any of its predecessors. The Executive shall, during and after the Executive’s employment with
the Company, communicate promptly and disclose to the Company, in such form as the Company
requests, all information, details and data pertaining to the aforementioned inventions, ideas,
disclosures and improvements. The Executive shall, during and after the Executive’s employment by
the Company, execute and deliver to the Company such formal transfers and assignments and such
other papers and documents as may be necessary by the Company to file and prosecute the patent
applications and, as to copyrightable material, to obtain copyright thereof. Any invention
relating to the business of the Company and disclosed by the Executive within one (1) year after
the Executive’s employment with the Company ceases shall be deemed to fall within the provisions of
Section 12.2 unless proved to have been first conceived and made following such termination or
expiration.

          12.3. Non-Solicitation of Employees. The Executive recognizes that the Executive
possesses and will possess confidential information about other employees of the Company and its
Affiliates relating to their education, experience, skills, abilities, compensation and benefits,
and inter-personal relationships with customer of the Company and its Affiliates. The Executive
recognizes that the information the Executive possesses and will possess about these other
employees is not generally known, is of substantial value to the Company and its Affiliates in
developing their business and in securing and retaining customers, and has been and
will be acquired by the Executive because of the Executive’s business position with the
Company and its Affiliates. The Executive agrees that at all times during the Executive’s

 

 

	 	 	 

	Wright Medical Technology, Inc.

Employment Agreement — David Stevens

Page 8

	 	

CONFIDENTIAL

DO NOT COPY

employment with the Company and for a period equal to the Executive’s Total Number of
Months thereafter, the Executive will not, directly or indirectly, solicit or recruit any employee
of the Company or its Affiliates for the purpose of being employed by the Executive or by any
competitor of the Company or its Affiliates on whose behalf the Executive is acting as an agent,
representative or employee and that the Executive will not convey such confidential information or
trade secrets about other employees of the Company and its Affiliates to any other Person;
provided, however, that it shall not constitute a solicitation or recruitment of employment in
violation of paragraph to discuss employment opportunities with any employee of the Company or its
Affiliates who has either first contacted the Executive or regarding whose employment the Executive
has discussed with and received the written approval of the Company’s Vice President, Human
Resources (or, if such position is vacant, the Company’s then Chief Executive Officer), prior to
making such solicitation or recruitment. In view of the nature of the Executive’s employment with
the Company, the Executive likewise agrees that the Company and its Affiliates would be irreparably
harmed by any such solicitation or recruitment in violation of the terms of this paragraph and that
the Company and its Affiliates shall therefore be entitled to preliminary and/or permanent
injunctive relief prohibiting the Executive from engaging in any activity or threatened activity in
violation of the terms of this paragraph and to any other relief available to them.

          12.4. Non-Interference and Non-competition. During the Executive’s employment by the
Company and its Affiliates and for a period of 12 months after such employment ceases, the Executive
shall not, directly or indirectly (whether as an officer, director, owner, employee, partner, or
other participant), engage in any Competitive Business. During this period, the Executive shall
not solicit or entice any agent, supplier, consultant, distributor, contractor, lessors or lessees
of the Company or its Affiliates to make any changes whatsoever in their current relationships with
the Company or its Affiliates, and will not assist any other Person or entity to interfere with or
dispute such relationship. In view of the nature of the Executive’s employment with the Company,
the Executive likewise agrees that the Company and its Affiliates would be irreparably harmed by
any such interference or competitive actions in violation of the terms of this paragraph and that
the Company and its Affiliates shall therefore be entitled to preliminary and/or permanent
injunctive relief prohibiting the Executive from engaging in any activity or threatened activity in
violation of the terms of this paragraph and to any other relief available to them.

          12.5. Release. The Executive and the Company agree that if the Executive’s employment
is terminated for any reason other than Cause or death, the Executive and the Company will execute
a release (the “Release”) of all claims substantially in the form attached hereto as Exhibit A
within forty-five (45) days after the applicable Date of Termination and does not revoke such
Release in accordance to the terms thereof. The Executive recognizes and agrees that
notwithstanding any other section to the contrary, this executed Release is required to be made
prior to any post employment payments of any kind under this Agreement. Furthermore, in the event
that the Executive is covered under the Age Discrimination in Employment Act (“ADEA”), the
Executive agrees to execute the ADEA Release of all ADEA claims substantially in the form attached
hereto as Exhibit B as provided in the ADEA Release.

 

 

	 	 	 

	Wright Medical Technology, Inc.

Employment Agreement — David Stevens

Page 9

	 	

CONFIDENTIAL

DO NOT COPY

          12.6. Cooperation with Legal Matters. Executive agrees to cooperate with the
Company and its designated attorneys, representatives and agents in connection with any actual or
threatened judicial, administrative or other legal or equitable proceeding in which the Company is
or may become involved. Upon reasonable notice, Executive agrees to meet with and provide to the
Company or its designated attorneys, representatives or agents all information and knowledge
Executive may have relating to the subject matter of any such proceeding. The Company agrees to
reimburse Executive for any reasonable costs incurred by Executive in providing such cooperation.

     13. Specific Remedies for Executive Breach of the Covenants as outlined in Section 13.
Without limiting the legal rights and remedies available to the Company, in the event of any breach
by the Executive of the covenants set forth in Section 12 above, the following actions may be taken
by the Company:

          13.1. The Company’s obligation to make any payment or provide any benefits to the Executive
under of this Agreement (except those covered by COBRA) shall cease immediately and permanently,
which shall not have any impact whatsoever on the Executive’s continuing obligations under Section
12;

          13.2. The Executive shall repay to the Company, within ten (10) days after the Executive
receives written demand therefore, an amount equal to ninety percent (90%) of the post employment
payments and benefits previously received by the Executive under this Agreement, plus interest on
such amount at an annual rate equal to the lesser of ten percent (10%) or the maximum non-usurious
rate under applicable law, from the dates on which such payments and benefits were received to the
date of repayment to the Company; and

          13.3. It is the desire and intent of the parties that the provisions of Section 12 be enforced
to the fullest extent permissible under the applicable laws in each jurisdiction in which
enforcement is sought. Accordingly, if any portion of Section 12 is adjudicated to be invalid or
unenforceable, Section 12 shall be deemed curtailed, whether as to time or location, to the minimum
extent required for its validity under applicable law and shall be binding and enforceable with
respect to the Executive as so curtailed, such curtailment to apply only with respect to the
operation of Section 12 in the jurisdiction in which the such adjudication is made. If a court in
any jurisdiction, in adjudicating the validity of Section 132, imposes any additional terms or
restrictions, then Section 12 shall be deemed amended to incorporate such additional terms or
restrictions.

          13.4. Executive agrees and acknowledges that Executive has received good and adequate
consideration for the covenants set forth in Section 12 in the form of employment, compensation and
benefits separate and independent of any post employment payments or potential payments in this
Agreement.

     14. Potential Impact of Accounting Restatements on Certain Bonuses and Profits.

 

 

	 	 	 

	Wright Medical Technology, Inc.

Employment Agreement — David Stevens

Page 10

	 	

CONFIDENTIAL

DO NOT COPY

          14.1. If the Company is required to prepare an accounting restatement of the Company’s
consolidated balance sheet or statement of operations affecting any reporting period that
transpires during the term of this Agreement due to the material noncompliance of the Company with
any financial requirements under the securities laws, the Company’s Board will be entitled to
determine whether the noncompliance was the result of knowing, intentional, fraudulent or illegal
conduct by the Executive, and if it so determines, to require the Executive to reimburse the
Company for (i) any bonus or other incentive-based or equity-based compensation received by the
Executive from the Company during the term of this Agreement and (ii) any profits realized from the
sale of securities of the issuer by the Executive during the term of this Agreement.

          14.2. In making the determination whether to seek reimbursement from Executive, the Board will
consider whether any bonus, incentive payment, equity award, or other compensation has been awarded
or received by the Executive during the term of this Agreement and whether such compensation was
based on any financial results or operating metrics that were satisfied as a result of the
Executive’s knowing, intentional, fraudulent or illegal conduct. The Board has sole discretion in
determining whether the Executive’s conduct has or has not met the standard of such forfeiture.

          14.3. If the Board determines that forfeiture is appropriate, such amounts shall be withheld
from any future amounts owed to the Executive as compensation. The Company may also commence legal
action to collect such sums as the Board determines is owed to the Company.

     15. Successors.

          15.1. Assignment by the Executive. This Agreement is personal to the Executive and
without the prior written consent of the Company shall not be assignable by the Executive otherwise
than by will or the laws of descent and distribution. This Agreement shall inure to the benefit of
and be enforceable by the Executive’s legal representatives.

          15.2. Successors and Assigns of the Company. This Agreement shall inure to the
benefit of and be binding upon the Company, its successors and assigns. The Company may not assign
this Agreement to any person or entity (except for a successor described in Section 15.3 below)
without the Executive’s written consent.

          15.3. Assumption. The Company shall require any successor (whether direct or
indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the
business and/or assets of the Company to assume expressly and agree to perform this Agreement in
the same manner and to the same extent that the Company would be required to perform it if no such
succession had taken place. As used in this Agreement, “Company” shall mean the Company as
hereinbefore defined and any successor to its business and/or assets as aforesaid that assumes and
agrees to perform this Agreement by operation of law or otherwise.

 

 

	 	 	 

	Wright Medical Technology, Inc.

Employment Agreement — David Stevens

Page 11

	 	

CONFIDENTIAL

DO NOT COPY

     16. Miscellaneous.

          16.1. Governing Law. This Agreement shall be governed by, construed under and
enforced in accordance with the laws of the State of Tennessee without regard to conflicts-of-laws
principles that would require the application of any other law. The captions of this Agreement are
not part of the provisions hereof and shall have no force or effect.

          16.2. Amendment. This Agreement may not be amended, modified, repealed, waived,
extended or discharged except by an agreement in writing of both parties. No person, other than
pursuant to a resolution of the Board or the Compensation Committee, shall have authority on behalf
of the Company to agree to amend, modify, repeal, waive, extend or discharge any provision of this
Agreement or anything in reference thereto.

          16.3. Assignment. This Agreement may be assigned, without the consent of the
Executive, by the Company to any person, partnership, corporation, and association or other entity
which has purchased all or substantially all the assets of the Company, provided that such assignee
assumes all the liabilities of the Company hereunder.

          16.4. Insurance. The Company may, at its election and for its benefit, insure the
Executive against accidental loss or death, and the Executive shall submit to such physical
examination and supply such information to the insurance company as may be required in connection
therewith; provided, however, that no detailed information concerning the Executive’s physical
examination will be provided to the Company or made available to the Company by the insurance
company.

          16.5. Waiver of Breach. A waiver by the Company or the Executive of a breach of any
provision of this Agreement by the other party shall not operate or be construed as a waiver of any
subsequent breach of the other party.

          16.6. Severability. The invalidity or unenforceability of any provision of this
Agreement shall not affect the validity or enforceability of any other provision of this Agreement.

          16.7. Notices. Any notice required or permitted to be given under this Agreement shall
be sufficient in writing and if sent by certified mail or express delivery to the Executive at
10047 French Springs Road, Lakeland, TN 38002, or to the Company at Wright Medical Technology,
Inc., Attention: General Counsel, 5677 Airline Road, Arlington, Tennessee 38002, or to such other
address as either party shall notify the other. Notices and communications shall be effective when
actually received by the addressee.

          16.8. Taxes. The Company may withhold from any amounts payable under this Agreement
such federal, state or local taxes as shall be required to be withheld pursuant to any applicable
law or regulation.

 

 

	 	 	 

	Wright Medical Technology, Inc.

Employment Agreement — David Stevens

Page 12

	 	

CONFIDENTIAL

DO NOT COPY

          16.9. Entire Agreement. This Agreement contains the entire agreement of the
parties with respect to the subject matter referred to herein and supersedes any and all prior
negotiations, understandings, arrangements, letters of intent, and agreements, whether written or
oral, between the Executive and the Company and its Affiliates, or any of its or their directors,
officers, employees or representatives with respect thereto.

          16.10. No Right of Employment. Nothing in this Agreement shall be construed as giving
the Executive any right to be retained in the employ of the Company or shall interfere in any way
with the right of the Company to terminate the Executive’s employment at any time, with or without
Cause.

          16.11. Unfunded Obligation. The obligations under this Agreement shall be unfunded.
Benefits payable under this Agreement shall be paid from the general assets of the Company. The
Company shall have no obligation to establish any fund or to set aside any assets to provide
benefits under this Agreement.

          16.12. Sarbanes-Oxley Act of 2002. Notwithstanding anything herein to the contrary,
if the Company determines, in its good faith judgment, that any provision of this Agreement is
likely to be interpreted as a personal loan prohibited by the Sarbanes-Oxley Act of 2002 and the
rules and regulations promulgated there under (the “Act”), then such provision shall be modified as
necessary or appropriate so as to not violate the Act; and if this cannot be accomplished, then the
Company shall use its best efforts to provide the Executive with similar, but lawful, substitute
benefit(s) at a cost to the Company not to significantly exceed the amount the Company would have
otherwise paid to provide such benefit(s) to the Executive. In addition, if the Executive is
required to forfeit or to make any repayment of any compensation or benefit(s) to the Company under
the Act or any other law, such forfeiture or repayment shall not constitute Good Reason.

          16.13. Attorneys’ Fees. Should either party file any action to enforce the terms
of this Agreement, the prevailing party shall be entitled to recover all reasonable attorneys’ fees
and litigation costs.

IN WITNESS WHEREOF, the parties have executed this Agreement as of the Effective Date.

AGREED AND ACCEPTED

	 	 	 	 	 

	WRIGHT MEDICAL TECHNOLOGY, INC.	 	DAVID D. STEVENS
	 
	 	 	 	 
	By:
    /s/ Edward A. Steiger

	 	/s/ David D.
Stevens
 

	Title:
Senior Vice President, Human Resources

	 	  
 

 

 

	 	 	 

	Wright Medical Technology, Inc.

Employment Agreement — David Stevens

Page 13

	 	

CONFIDENTIAL

DO NOT COPY

EXHIBIT A

MUTUAL RELEASE AGREEMENT

     This Mutual Release Agreement (this “Agreement”), is made and entered into this __ day
of_________,_______ , , by and between Wright Medical Technology, Inc. (the “Company”), a
corporation organized and existing under the laws of the State of Delaware with its principal place
of business at 5677 Airline Road, Arlington, Tennessee 38002, and David D. Stevens (the
“Executive”).

     The Executive, on behalf of the Executive and the Executive’s heirs, executors,
administrators, successors and assigns, whether herein named or referred to or not, does hereby
release, discharge, and acquit and by these presents does hereby release, acquit, and forever
discharge Company, its successors and assigns, its agents, servants, and employees, its divisions,
subdivisions, and affiliates (collectively, the “Company”), of and from any and all past, present,
and future claims, counterclaims, demands, actions, causes of action, liabilities, damages, costs,
loss of services, expenses, compensation, third-party actions, suits at law or in equity, of every
nature and description, whether known or unknown, suspected or unsuspected, foreseen, or
unforeseen, real or imaginary, actual or potential, and whether arising at law or in equity, under
the common law, state or federal law, or any other law, or otherwise, including, but not limited
to, any claims that have been or might have been asserted as a result of the establishment or
termination of the employer-employee relationship, hereinafter collectively referred to as claims.
It is the intention of the parties hereto to effect a full and final general release of all such
claims. It is expressly understood and agreed that this release and agreement is intended to
cover, and does cover, not only all now known injuries, losses, and damages, but any future
injuries, losses, and damages not now known or anticipated, but which may later develop or be
discovered, including all the effects and consequences thereof.

     Executive does hereby declare that the Executive does understand, covenant, and agree that the
Executive will not make any claims or demands, or file any legal proceedings against Company or
join Company as a party to any claim, demand, or legal proceedings nor shall Executive proceed
against any other party, person, firm, or corporation on the claims described above except as is
necessary in order to enforce the terms and conditions of this Release and the Severance Pay
Agreement.

THE FILING OF ANY CLAIM, DEMAND, OR ANY AND ALL OTHER LEGAL PROCEEDINGS, BY THE EXECUTIVE, AGAINST
COMPANY, SHALL BE DEEMED TO BE A MATERIAL BREACH OF THE TERMS OF THIS AGREEMENT. SUCH BREACH SHALL,
IMMEDIATELY, TERMINATE COMPANY’S DUTY TO PAY ANY FURTHER SUMS TO EXECUTIVE AND SHALL ALSO BIND
EXECUTIVE TO REPAY ANY AND ALL SUMS PAID TO EXECUTIVE PURSUANT TO THE TERMS OF THIS AGREEMENT.
ADDITIONALLY, EXECUTIVE SHALL INDEMNIFY AND HOLD HARMLESS COMPANY FROM ANY AND ALL JUDGMENTS,
COSTS, EXPENSES, OR ATTORNEY

 

 

	 	 	 

	Wright Medical Technology, Inc.

Employment Agreement — David Stevens

Page 14

	 	

CONFIDENTIAL

DO NOT COPY

FEES WHATSOEVER ARISING ON ACCOUNT OF THE FILING OF ANY SUCH CLAIM, DEMAND, OR OTHER LEGAL
PROCEEDINGS BY THE EXECUTIVE.

     It is further understood and agreed that the acceptance of the consideration more fully
described in the Severance Pay Agreement between the parties is in full accord and satisfaction of
any obligations, claims, and/or disputes that Executive may have with Company.

     And the parties hereby declare, understand, covenant, and agree that the terms of the
Severance Pay Agreement, and the amount stated therein, are the sole consideration for this release
and agreement and that the parties voluntarily accept said consideration for the purpose of making
a full and final compromise, adjustment and settlement of all claims for injuries, losses, and
damages resulting, or to result, from said claims.

     Except for any claim under Sections 12, 13 or 14 of the Employment Agreement, the Company, on
behalf of itself, its agents, servants, and employees, its divisions, subdivisions, and affiliates
(collectively, the “Company”), successors and assigns, whether herein named or referred to or not,
does hereby release, discharge, and acquit and by these presents does hereby release, acquit, and
forever discharge Executive, the Executive’s heirs, executors, administrators, successors and
assigns, of and from any and all past, present, and future claims, counterclaims, demands, actions,
causes of action, liabilities, damages, costs, loss of services, expenses, compensation,
third-party actions, suits at law or in equity, of every nature and description, whether known or
unknown, suspected or unsuspected, foreseen, or unforeseen, real or imaginary, actual or potential,
and whether arising at law or in equity, under the common law, state or federal law, or any other
law, or otherwise, including, but not limited to, any claims that have been or might have been
asserted as a result of the establishment or termination of the employer-employee relationship,
hereinafter collectively referred to as claims. It is the intention of the parties hereto to
effect a full and final general release of all such claims. It is expressly understood and agreed
that this release and agreement is intended to cover, and does cover, not only all now known
injuries, losses, and damages, but any future injuries, losses, and damages not now known or
anticipated, but which may later develop or be discovered, including all the effects and
consequences thereof.

     Company does hereby declare that the Company does understand, covenant, and agree that the
Company will not make any claims or demands, or file any legal proceedings against Executive or
join Executive as a party to any claim, demand, or legal proceedings nor shall Company proceed
against any other party, person, firm, or corporation on the claims described above except as is
necessary in order to enforce the terms and conditions of this Release and the Severance Pay
Agreement.

THE FILING OF ANY CLAIM, DEMAND, OR ANY AND ALL OTHER LEGAL PROCEEDINGS, BY THE COMPANY, AGAINST
EXECUTIVE, SHALL BE DEEMED TO BE A MATERIAL BREACH OF THE TERMS OF THIS AGREEMENT. SUCH BREACH
SHALL, IMMEDIATELY, TERMINATE EXECUTIVE’S DUTY TO COMPLY WITH THE NON-SOLICIATION,
NON-INTERFERENCE, AND NON-COMPETITION COVENANTS OF THE SEVERANCE PAY AGREEMENT BETWEEN THE PARTIES.
ADDITIONALLY,

 

 

	 	 	 

	Wright Medical Technology, Inc.

Employment Agreement — David Stevens

Page 15

	 	

CONFIDENTIAL

DO NOT COPY

COMPANY SHALL INDEMNIFY AND HOLD HARMLESS EXECUTIVE FROM ANY AND ALL JUDGMENTS, COSTS,
EXPENSES, OR ATTORNEY FEES WHATSOEVER ARISING ON ACCOUNT OF THE FILING OF ANY SUCH CLAIM, DEMAND,
OR OTHER LEGAL PROCEEDINGS BY THE COMPANY.

     It is further understood and agreed that the acceptance of the consideration more fully
described in the Employment Agreement between the parties is in full accord and satisfaction of any
obligations, claims, and/or disputes that Company may have with Executive.

     It is further understood and agreed that this is the full and complete understanding of the
parties, that it is the integrated memorial of their agreement and that there are no other written
or oral understandings, agreements, covenants, promises, or arrangements, directly or indirectly
connected with this release, that are not incorporated herein. The terms of this release are
contractual and are not mere recitals.

     Notwithstanding the foregoing, nothing in this Release shall release either party from
obligations resulting from the Employment Agreement nor prohibit either party from seeking the
enforcement of the Employment Agreement.

     IN WITNESS WHEREOF, the parties executed this Release as of the Effective Date.

AGREED AND ACCEPTED

	 	 	 	 	 

	WRIGHT MEDICAL TECHNOLOGY, INC.	 	EXECUTIVE
	 
	 	 	 	 
	By:

	 	 
	

	 	 

	 	 
 David
D. Stevens
	Title:

	 	 

 

 

	 	 	 

	Wright Medical Technology, Inc.

Employment Agreement — David Stevens

Page 16

	 	

CONFIDENTIAL

DO NOT COPY

EXHIBIT B

ADEA RELEASE AND AGREEMENT

     As a material inducement to Wright Medical Technology, Inc. (hereinafter referred to as
“Wright” or “Employer”) to enter into this ADEA Release and Agreement (the “Release or “Agreement”)
with David D. Stevens (hereinafter referred to as “Executive”) (for Executive, Executive’s heirs,
executors, administrators and assigns), Executive hereby unconditionally releases and forever
discharges Wright and each of the Wright’s stockholders, predecessors, successors, assigns, agents,
directors, officers, employees, representatives, attorneys, divisions, subsidiaries, affiliates and
all persons acting by, through, under, or in concert with any of them from any and all charges,
complaints, claims, liabilities, obligations, promises, agreements, controversies, damages,
actions, causes of action, suits, rights, demands, costs, losses, debts and expenses (including
attorney’s fees and costs actually incurred) of any nature whatsoever, known or unknown, suspected
or unsuspected, including, but not limited to, rights, under the Age Discrimination in Employment
Act of 1967, as amended from time to time, and other federal, state, or local laws prohibiting
discrimination, any claims the employee may have with regard to Executive’s hiring, employment, or
electing the re-employment program and termination of employment claims growing out of any legal
restrictions on Wright’s right to terminate its employees (“Claim” or Claims”), which the
Executive now has, owns or holds, or claims to have owned or held, or which the Executive at any
time hereinafter may have owned or held or claimed to have owned or held against Wright.

     To comply with the Older Workers Benefit Protection Act of 1990, as amended from time to time,
the Release and Agreement has advised Executive of the legal requirements of this Act and fully
incorporates the legal requirements by reference into this Agreement as follows:

	 	a.	 	This Agreement is written in layman’s terms, and the Executive understands and
comprehends its terms;
	 
	 	b.	 	Executive has been advised of Executive’s rights to consult an attorney to
review the Agreement;
	 
	 	c.	 	Executive does not waive any rights or claims that may arise after the date the
Release is executed;
	 
	 	d.	 	Executive is receiving consideration beyond anything of value to which he
already is entitled;
	 
	 	e.	 	Executive has been given a reasonable period of time to consider this Agreement
(45 days).

 

 

	 	 	 

	Wright Medical Technology, Inc.

Employment Agreement — David Stevens

Page 17

	 	

CONFIDENTIAL

DO NOT COPY

As consideration for this Release, Wright agrees to provide the items listed in the Employment
Agreement dated     . The Executive enters into this Release with full knowledge of its contents
and enters into this Agreement voluntarily.

AGREED AND ACCEPTED

	 	 	 	 	 	 	 

	EXECUTIVE:	 	WRIGHT MEDICAL TECHNOLOGY, INC.
	 
	 	 	 	 	 	 
	I acknowledge that I fully understand
and agree that this Agreement may be
pleaded by Wright Medical Technology,
Inc. as a complete defense to any claim
which hereafter may be asserted by me or
a claim against Wright Medical
Technology, Inc. for or on account of
any matter or thing whatsoever arising
out of the employment relationship or my
termination from active employment.
	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 
	 

David D. Stevens

	 	By:

	 	 
	 

	 	Title:

	 	 

NOTE: EXECUTIVE IS HEREBY ADVISED OF HIS OR HER RIGHT TO RESCIND AND NULLIFY THIS AGREEMENT, WHICH
RIGHT MUST BE EXERCISED, IF AT ALL, WITHIN SEVEN (7) DAYS OF THE DATE OF EXECUTIVE’S SIGNATURE.
EXECUTIVE MUST REVOKE RELEASE BY LETTER TO WRIGHT MEDICAL TECHNOLOGY, INC., ATTENTION: GENERAL
COUNSEL, 5677 AIRLINE ROAD, ARLINGTON, TN 38002, WITHIN SEVEN (7) DAYS. NO CONSIDERATION SHALL BE
CONVEYED UNTIL SUCH TIME PERIOD HAS EXPIRED.exv4w2

Exhibit 4.2

AMENDMENT NO. 1 TO

STOCKHOLDER RIGHTS AGREEMENT

     This Amendment No. 1 (the “Amendment”) is dated as of May 4, 2011 and amends that certain
Stockholder Rights Agreement (the “Rights Agreement”), dated as of August 14, 2009, between Kendle
International Inc., an Ohio corporation (the “Company”) and American Stock Transfer & Trust
Company, LLC, a New York limited liability trust company, as Rights Agent (the “Rights Agent”).

     WHEREAS, the Company intends to enter into an Agreement and Plan of Merger (as it may be
amended or supplemented from time to time) (the “Merger Agreement”), by and among the Company, INC
Research, LLC, a Delaware limited liability company (the “Parent”) and Triangle Two Acquisition Corp., an Ohio
corporation and a subsidiary of Parent (the “Merger Sub”);

     WHEREAS, on May 4, 2011, the Board of Directors of the Company determined it is in the best
interests of the Company and its stockholders to amend the Rights Agreement on the terms set forth
herein;

     WHEREAS, in accordance with Section 27 of the Rights Agreement, prior to the occurrence of a
Section 11(b) Event (as defined in the Rights Agreement), the Company and the Rights Agent shall,
if the Board of Directors of the Company so directs, supplement or amend any provision of this
Agreement as the Board of Directors of the Company may deem necessary or desirable without the
approval of any holders of certificates representing shares of Common Stock of the Company; and

     WHEREAS, the Rights Agent is hereby directed to join in the amendment to the Rights Agreement
as set forth herein.

     NOW, THEREFORE, in consideration of the promises and the mutual agreements herein set forth,
the parties hereby agree as follows:

AGREEMENT

     1. Amendment of the Rights Agreement.

          (a) Section 1(a) of the Rights Agreement is hereby amended by inserting the following
sentence immediately after the last sentence in the definition of “Acquiring Person”:

“Notwithstanding anything in this Section 1(a) or otherwise in this
Agreement to the contrary, none of INC Research, LLC (“Parent”), Triangle
Two Acquisition Corp. (“Merger Sub”), or any of their respective Affiliates
or Associates, (collectively, the “Exempt INC Persons”), either individually
or collectively, shall be deemed to be an “Acquiring Person” by virtue of or
as a result of (A) the approval, adoption, execution, delivery or
performance of the Merger Agreement, (B) the public or other announcement or
disclosure of the Merger, the Merger Agreement or any

 

 

of the other transactions contemplated by the Merger Agreement or (C) the
consummation of the Merger at the Effective Time or any of the other
transactions contemplated by the Merger Agreement (the transactions
described in clauses (A), (B) and (C), together with any related
transactions, the “Exempt INC Transactions”). “Effective Time” and “Merger”
shall have the meanings set forth in the Merger Agreement and “Merger
Agreement” shall mean the Agreement and Plan of Merger, dated as of May 4,
2011 by and between the Company, Parent, and Merger Sub, an Ohio
corporation, as it may be amended or supplemented from time to time.”

               (b) Section 1(f) of the Rights Agreement is hereby amended by inserting the following
new clause (vi) immediately after clause (v):

“(vi) Notwithstanding anything in this Section 1(f) or otherwise in this
Agreement to the contrary, none of the Exempt INC Persons, either
individually or collectively, shall be deemed the Beneficial Owner of or
deemed to “Beneficially Own” or have “Beneficial Ownership” of any
securities beneficially owned by any other Exempt Persons by virtue of or as
a result of any Exempt INC Transaction.”

               (c) Section 1(hh) of the Rights Agreement is hereby amended by inserting the following
sentence immediately after the last sentence in the definition of “Stock Acquisition Date”:

“Notwithstanding anything in this Section 1(hh) or otherwise in this
Agreement to the contrary, a Stock Acquisition Date shall not be deemed to
have occurred by virtue of or as a result of any Exempt INC Transaction.”

               (d) Section 3(a) of the Rights Agreement is hereby amended by inserting the following
sentence immediately after the last sentence of Section 3(a):

“Notwithstanding anything to the contrary in Section 3(a) hereof or
otherwise in the Agreement to the contrary, a Distribution Date shall not be
deemed to have occurred by virtue of or as a result of any Exempt INC
Transaction.”

               (e) Section 11(b) of the Rights Agreement is hereby amended by inserting the following
sentence immediately after the last sentence of Section 11(b):

“Notwithstanding anything in Section 11 or Section 13 hereof or otherwise in
this Agreement to the contrary, a Section 11(b) Event shall not be deemed to
have occurred by virtue of or as a result of an Exempt INC Transaction.”

               (f) Section 13(a) of the Rights Agreement is hereby amended by inserting the following
sentence immediately after the last sentence of Section 13(a):

2

 

“Notwithstanding anything in Section 11 or Section 13 hereof or otherwise in
this Agreement to the contrary, a Section 13 Event shall not be deemed to
have occurred by virtue of or as a result of an Exempt INC Transaction.”

               (g) Section 7(a) of the Rights Agreement is hereby amended and replaced in its entirety
with the following:

“(a) Subject to Section 7(e) hereof, the registered holder of any Right
Certificate may exercise the Rights evidenced thereby (except as otherwise
provided herein) in whole or in part at any time after the Distribution Date
upon surrender of the Right Certificate, with the form of election to
purchase and the certificate on the reverse side thereof duly executed, to
the Rights Agent at the office or offices of the Rights Agent designated for
such purpose, together with payment of the aggregate Exercise Price for the
total number of one one-thousandths (1/1,000) of a share of Common Stock (or
other securities, cash or other assets, as the case may be) as to which such
surrendered Rights are then exercised, at or prior to the earlier of (i) the
Close of Business on the fifth anniversary of the Record Date (the “Final
Expiration Date”), (ii) the time at which the Rights are redeemed as
provided in Section 23 hereof (the “Redemption Date”), (iii) the time at
which such Rights are exchanged as provided in Section 24 hereof (the
“Exchange Date”) or (iv) immediately prior to the Effective Time of the
Merger (but only if the Effective Time shall occur) (the earliest of (i),
(ii), (iii) or (iv) being herein referred to as the “Expiration Date”).
Except as set forth in Section 7(e) hereof and notwithstanding any other
provision of this Agreement, any Person who prior to the Distribution Date
becomes a record holder of shares of Common Stock of the Company may
exercise all of the rights of a registered holder of a Right Certificate
with respect to the Rights associated with such shares of Common Stock of
the Company in accordance with the provisions of this Agreement, as of the
date such Person becomes a record holder of shares of Common Stock of the
Company.”

               (h) A new Section 36 with the heading “Termination at the Effective Time” is hereby
added to the Rights Agreement reading in its entirety as follows:

“(a) This Agreement and the Rights established hereby will terminate in all
respects immediately prior to the Effective Time.

(b) The Rights Agent shall not be subject to, nor be required to comply
with, or determine if any event has occurred under (including, but not
limited to, the occurrence of the Merger or the Effective Time), or any
Person has complied with, the Merger Agreement or any agreements and
documents related to or referred to in the Merger Agreement or any other
agreement between or among the parties thereto, even though reference

3

 

thereto may be made in this Agreement, or to comply with any notice,
instruction, direction, request or other communication, paper or document
other than as expressly set forth in this Agreement.”

               (i) Section 26 of the Rights Agreement is amended and restated in part to update the
address of the Rights Agent by deleting the language which reads:

“Herbert J. Lemmer

American Stock Transfer & Trust Company

59 Maiden Lane

New York, NY 10038

Attention: General Counsel”

and replacing such language, in its entirety, with the following:

“American Stock Transfer & Trust Company, LLC

6201 15th Avenue

Brooklyn, NY 11219

Attention: Corporate Trust Department

With a copy to:

American Stock Transfer & Trust Company, LLC

6201 15th Avenue

Brooklyn, NY 11219

Attention: General Counsel”

     2. Termination of Merger Agreement. If the Merger Agreement is terminated, then from
and after such time this Amendment shall be of no further force and effect and the Agreement shall
remain exactly the same as it existed immediately prior to execution of this Amendment. The
Company hereby agrees to notify the Rights Agent promptly upon the termination of the Merger
Agreement.

     3. Notice of Effective Time. The Company agrees to notify the Rights Agent promptly
after the occurrence of the Effective Time, which notice shall specify (i) that the Effective Time
has occurred, and (ii) the date upon which this Agreement and the Rights established hereby were
terminated.

     4. No Other Amendment; Effect of Amendment. Except as and to the extent expressly
modified by this Amendment, the Rights Agreement and the exhibits thereto shall remain in full
force and effect in all respects without any modification. By executing this Amendment below, the
Company certifies that this Amendment has been executed and delivered in compliance with the terms
of Section 27 of the Rights Agreement. This Amendment shall be deemed an amendment to the Rights
Agreement and shall become effective and shall be deemed to be in force and effect immediately
prior to the execution of the Merger Agreement. In the event of a conflict or inconsistency between
this Amendment and the Rights Agreement and the exhibits thereto, the provisions of this Amendment
shall govern.

4

 

     5. Counterparts. This Amendment may be executed in any number of counterparts and each
of such counterparts shall for all purposes be deemed to be an original, and all such counterparts
shall together constitute but one and the same instrument. A signature to this Amendment
transmitted electronically shall have the same authority, effect, and enforceability as an original
signature.

     6. Severability. If any term, provision, covenant or restriction of this Amendment is
held by a court of competent jurisdiction or other authority to be invalid, void or unenforceable,
the remainder of the terms, provisions, covenants and restrictions of this Amendment shall remain
in full force and effect and shall in no way be affected, impaired or invalidated.

     7. Miscellaneous. This Amendment shall be deemed to be a contract made under the laws
of the State of Ohio and for all purposes shall be governed by and construed in accordance with the
laws of such State applicable to contracts to be made and to be performed entirely within such
State.

[Remainder of Page Intentionally Left Blank. Signature Page Follows.]

5

 

     IN WITNESS WHEREOF, the parties hereto have caused this Amendment No. 1 to be duly executed as
an instrument under seal and attested, all as of the day and year first above written.

	 	 	 	 	 	 	 

	 	 	Kendle International Inc.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Jarrod B. Pontius
 

	 	 
	 

	 	Name:
	 	Jarrod B. Pontius	 	 
	 

	 	Title:
	 	Vice President, Chief Legal Officer and
Secretary	 	 
	 
	 	 	 	 	 	 
	 	 	American Stock Transfer & Trust Company, LLC

as Rights Agent	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Karishma P. Kadian
 

	 	 
	 

	 	Name:
	 	Karishma P. Kadian	 	 
	 

	 	Title:
	 	Counsel	 	 

6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00188-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00188-of-00352.parquet"}]]